urofollitropin


Also found in: Wikipedia.

urofollitropin

 [u″ro-fol´ĭ-tro″pin]
a preparation of gonadotropins from the urine of postmenopausal women; it contains follicle-stimulating hormone and is used in conjunction with human chorionic gonadotropin to induce ovulation in the treatment of female infertility and to stimulate multiple oocyte development in ovulatory patients utilizing assisted reproductive technologies. Administered by subcutaneous injection.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

ur·o·fol·li·tro·pin

(yūr'ō-fol'i-trō'pin),
A preparation of gonadotropin extracted from the urine of postmenopausal women, used in conjunction with human chorionic gonadotropin to induce ovulation.
See also: menotropins.
Farlex Partner Medical Dictionary © Farlex 2012

Bravelle

A lyophilised formulation of follicle-stimulating hormone purified from the urine of postmenopausal women, which is used to induce ovulation and as part of the regimen for assisted reproductive technologies—e.g., in vitro fertilisation.

Contraindications Bravelle
• High FSH level indicating primary ovarian failure;
• Uncontrolled thyroid and adrenal dysfunction;
• An organic intracranial lesion—especially pituitary tumours;
• Any cause of infertility other than anovulation;
• Abnormal bleeding of undetermined origin;
• Ovarian cysts or enlargement not due to polycystic ovary syndrome;
• Prior hypersensitivity to urofollitropins, purified;
• Pregnancy.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

u·ro·fol·li·tro·pin

(yūr'ō-fol'i-trō'pin)
A preparation of gonadotropin extracted from the urine of postmenopausal women, used in conjunction with human chorionic gonadotropin to induce ovulation.
See also: menotropins
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive ?
Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin. Euro J Endocrinol 1997; 136: 488-92.
On the same day, ovarian stimulation was carried out with recombinant FSH (follitropin [alpha]; rFSH; Gonal-F, Merck Serono, France, or follitropin [beta]; Puregon, MSD, France), urinary FSH (urofollitropin, Fostimon, France), or hMG (menotropin, Menopur, France) at a starting dose of 75 IU/day from the second day of the cycle.
Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation.